trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Thyroid Neoplasms D013964 33 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Stroke D020521 32 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Cardiomegaly D006332 31 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Endometriosis D004715 29 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Zhou Q et al. TGFbeta mediated transition of corneal fibroblasts from a proinflammatory state to a profibrotic state through modulation of histone acetylation. 2010 J. Cell. Physiol. pmid:20232294
Chen WP et al. Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis. 2010 Mol. Biol. Rep. pmid:20237852
Urbinati G et al. Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy. 2010 Int J Pharm pmid:20603204
Sharma P et al. Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. 2010 Mol. Cancer pmid:20609221
Repouskou A et al. The circadian expression of c-MYC is modulated by the histone deacetylase inhibitor trichostatin A in synchronized murine neuroblastoma cells. 2010 Chronobiol. Int. pmid:20560708
Tessema M et al. Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. 2010 Oncogene pmid:20562917
Kashiwagi Y et al. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines. 2010 Invest. Ophthalmol. Vis. Sci. pmid:19737884
Kaimori A et al. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes. 2010 Hepatology pmid:20564330
Awe S and Renkawitz-Pohl R Histone H4 acetylation is essential to proceed from a histone- to a protamine-based chromatin structure in spermatid nuclei of Drosophila melanogaster. 2010 Syst Biol Reprod Med pmid:20170286
Akiba Y et al. Histone deacetylase inhibitors de-repress tyrosine hydroxylase expression in the olfactory bulb and rostral migratory stream. 2010 Biochem. Biophys. Res. Commun. pmid:20170631
Costa-Borges N et al. Comparison between the effects of valproic acid and trichostatin A on the in vitro development, blastocyst quality, and full-term development of mouse somatic cell nuclear transfer embryos. 2010 Cell Reprogram pmid:20698782
Angst E et al. Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells. 2010 Pancreas pmid:20173668
Lee HS et al. Enhanced histone acetylation in somatic cells induced by a histone deacetylase inhibitor improved inter-generic cloned leopard cat blastocysts. 2010 Theriogenology pmid:20708232
Zhang L et al. Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. 2010 World J Surg pmid:20177680
Tokoro M et al. Deposition of acetylated histones by RNAP II promoter clearance may occur at onset of zygotic gene activation in preimplantation mouse embryos. 2010 J. Reprod. Dev. pmid:20710121
Peng CY et al. Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines. 2010 Leuk. Lymphoma pmid:20038232
Li RJ et al. Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance. 2010 Ann. Oncol. pmid:20038517
Nordén R et al. Inhibition of protein deacetylation augments herpes simplex virus type 1-activated transcription of host fucosyltransferase genes associated with virus-induced sLex expression. 2010 Arch. Virol. pmid:20039087
Wang X et al. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells. 2010 Blood pmid:20858855
Gushchina SV et al. [Cellular aspects of regulation of nuclear factor kappaB (NF-kappabeta) transcriptional activity in sensory neurons in vitro]. 2010 Morfologiia pmid:20960709
Krishnan M et al. HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. 2010 Oncogene pmid:19881542
Ninios YP et al. Histone H1 subtype preferences of DFF40 and possible nuclear localization of DFF40/45 in normal and trichostatin A-treated NB4 leukemic cells. 2010 Apoptosis pmid:19882353
Hui KF and Chiang AK Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death. 2010 Int. J. Cancer pmid:19816947
Pollack BP et al. Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation. 2009 May-Jun Photochem. Photobiol. pmid:19076306
Chen Z et al. BCL11A represses HBG transcription in K562 cells. 2009 Mar-Apr Blood Cells Mol. Dis. pmid:19153051
Wang L et al. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance. 2009 Mar-Apr Immunol. Cell Biol. pmid:19172156
Allritz C et al. Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels. 2009 Jul-Aug Neurochem. Int. pmid:19428803
Cecconi D et al. Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 2009 Proteomics pmid:19294695
Ikeda S et al. Enhancement of histone acetylation by trichostatin A during in vitro fertilization of bovine oocytes affects cell number of the inner cell mass of the resulting blastocysts. 2009 Zygote pmid:19356267
Morita K et al. Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated brain-derived neurotrophic factor gene expression in rat C6 glioma cells. 2009 J. Neurosci. Res. pmid:19360904
von Burstin J et al. E-cadherin regulates metastasis of pancreatic cancer in vivo and is suppressed by a SNAIL/HDAC1/HDAC2 repressor complex. 2009 Gastroenterology pmid:19362090
Yang X et al. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells. 2009 PLoS ONE pmid:19340297
Slattery EL et al. Epigenetic influences on sensory regeneration: histone deacetylases regulate supporting cell proliferation in the avian utricle. 2009 J. Assoc. Res. Otolaryngol. pmid:19340485
Vilar E et al. Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway. 2009 Clin. Cancer Res. pmid:19351759
Lu SC et al. The essential role of Oct-2 in LPS-induced expression of iNOS in RAW 264.7 macrophages and its regulation by trichostatin A. 2009 Am. J. Physiol., Cell Physiol. pmid:19279235
Luo SF et al. Activation of ROS/NF-kappaB and Ca2+/CaM kinase II are necessary for VCAM-1 induction in IL-1beta-treated human tracheal smooth muscle cells. 2009 Toxicol. Appl. Pharmacol. pmid:19281832
Giannini G et al. N-Hydroxy-(4-oxime)-cinnamide: a versatile scaffold for the synthesis of novel histone deacetylase [correction of deacetilase] (HDAC) inhibitors. 2009 Bioorg. Med. Chem. Lett. pmid:19285395
Meng CF et al. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on P16, hMLH1 and MGMT genes and DNA methylation in human gastric cancer cells]. 2009 Zhonghua Wei Chang Wai Ke Za Zhi pmid:19742343
Dombrowsky H et al. Conserved responses to trichostatin A in rodent lungs exposed to endotoxin or stretch. 2009 Pulm Pharmacol Ther pmid:19744573
Dandrea M et al. MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines. 2009 Nucleic Acids Res. pmid:19745053
Lugrin J et al. Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation. 2009 Biochim. Biophys. Acta pmid:19747950
Cervera RP et al. Trichostatin A affects histone acetylation and gene expression in porcine somatic cell nucleus transfer embryos. 2009 Theriogenology pmid:19765811
Diplas AI et al. Demonstration of all-or-none loss of imprinting in mRNA expression in single cells. 2009 Nucleic Acids Res. pmid:19767614
Ma XX et al. Histone deacetylase inhibitor trichostatin A modulates cell cycles in A2780 human ovarian cancer cell lines. 2009 Eur. J. Gynaecol. Oncol. pmid:19697617
Chen FQ et al. Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea. 2009 J. Neurochem. pmid:19141081
Zhao W et al. Histone deacetylase inhibitor, trichostatin A, affects gene expression patterns during morphogenesis of chicken limb buds in vivo. 2009 Cells Tissues Organs (Print) pmid:19147985
Giustiniani J et al. Tubulin acetylation favors Hsp90 recruitment to microtubules and stimulates the signaling function of the Hsp90 clients Akt/PKB and p53. 2009 Cell. Signal. pmid:19136058
Chen Y et al. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. 2009 Eur J Med Chem pmid:19136179
Cowell RM et al. Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells. 2009 Biochem. Biophys. Res. Commun. pmid:19118529
Wiesen JL and Tomasi TB Dicer is regulated by cellular stresses and interferons. 2009 Mol. Immunol. pmid:19118902
Togi S et al. HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A. 2009 Biochem. Biophys. Res. Commun. pmid:19121623
Dje N'Guessan P et al. Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells. 2009 Arterioscler. Thromb. Vasc. Biol. pmid:19122173
Mavis CK et al. Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors. 2009 Prostate pmid:19444856
Samuni Y et al. The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation. 2009 Free Radic. Biol. Med. pmid:19447172
Gavin DP et al. Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. 2009 J Psychiatry Neurosci pmid:19448855
Astrand C et al. Histone acetylation characterizes chromatin presetting by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV promoter. 2009 Exp. Cell Res. pmid:19463811
Riester D et al. Non-isotopic dual parameter competition assay suitable for high-throughput screening of histone deacetylases. 2009 Bioorg. Med. Chem. Lett. pmid:19457659
Woodfield GW et al. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure. 2009 Clin. Cancer Res. pmid:19458056
Hauswald S et al. Histone deacetylase inhibitors induce a very broad, pleiotropic anticancer drug resistance phenotype in acute myeloid leukemia cells by modulation of multiple ABC transporter genes. 2009 Clin. Cancer Res. pmid:19458058
Arce L et al. Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression. 2009 BMC Cancer pmid:19460168
Petr J et al. Histone deacetylase inhibition improves meiotic competence but not developmental competence in growing pig oocytes. 2009 Zygote pmid:19460191
Soriano FX et al. Role of histone acetylation in the activity-dependent regulation of sulfiredoxin and sestrin 2. 2009 Epigenetics pmid:19430206
Dubois F et al. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni. 2009 Mol. Biochem. Parasitol. pmid:19538992
Ma XL et al. [Construction of anti-sense cDNA library of human breast cancer cells during apoptosis induced by trichostatin A and preliminary screening of essential genes]. 2009 Zhonghua Yi Xue Za Zhi pmid:19567099
Moon C et al. Use of epigenetic modification to induce FOXP3 expression in naïve T cells. 2009 Transplant. Proc. pmid:19545742
Thiel A et al. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. 2009 Clin. Cancer Res. pmid:19584167
Rahim R and Strobl JS Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. 2009 Anticancer Drugs pmid:19584707
Nadasi E et al. Epigenetic modifiers exacerbate oxidative stress in renal proximal tubule cells. 2009 Anticancer Res. pmid:19528494
Giustiniani J et al. Basal endothelial nitric oxide synthase (eNOS) phosphorylation on Ser(1177) occurs in a stable microtubule- and tubulin acetylation-dependent manner. 2009 Exp. Cell Res. pmid:19632222
Liu X et al. The improvement of adenovirus vector production by increased expression of coxsackie adenovirus receptor. 2009 Biotechnol. Lett. pmid:19330491
Hollosi P et al. Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells. 2009 Int. J. Cancer pmid:19330836
Chen J et al. E1A has no effect on LPS-induced IL-6 secretion in rat alveolar epithelial cells. 2009 Respiration pmid:19299891
Yeh JR et al. Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation. 2009 Nat. Chem. Biol. pmid:19172146
Shao GB et al. Effect of trychostatin A treatment on gene expression in cloned mouse embryos. 2009 Theriogenology pmid:19246084
Cunneen TS et al. In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. 2009 Arch. Ophthalmol. pmid:19365017
Charrier C et al. Synthesis and modeling of new benzofuranone histone deacetylase inhibitors that stimulate tumor suppressor gene expression. 2009 J. Med. Chem. pmid:19385600
Yap OW et al. Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells. 2009 Anticancer Res. pmid:19331143
Puca R et al. HIPK2 modulates p53 activity towards pro-apoptotic transcription. 2009 Mol. Cancer pmid:19828042
Röhrs S et al. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia. 2009 Mol. Cancer pmid:19835597
Wang Y et al. HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells. 2009 Neurosci. Lett. pmid:19835929
Mastitskaya S and Denecke B Human spongiosa mesenchymal stem cells fail to generate cardiomyocytes in vitro. 2009 J Negat Results Biomed pmid:19903342
Sun F et al. Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells. 2009 Mol. Cancer Ther. pmid:19934278
Koh HS et al. Twist2 regulates CD7 expression and galectin-1-induced apoptosis in mature T-cells. 2009 Mol. Cells pmid:19937140
Peng DF et al. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. 2009 Gut pmid:18664505
Lu MC et al. Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. 2009 Arch. Toxicol. pmid:18709356
Sharma A et al. Trichostatin a inhibits corneal haze in vitro and in vivo. 2009 Invest. Ophthalmol. Vis. Sci. pmid:19168895
Zubia A et al. Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity. 2009 Oncogene pmid:19169274
Meng Q et al. Live birth of somatic cell-cloned rabbits following trichostatin A treatment and cotransfer of parthenogenetic embryos. 2009 Cloning Stem Cells pmid:19196041
Gray SG et al. Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications. 2009 Eur. J. Cancer pmid:19818596
Zhang F et al. Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells. 2009 Cancer Biol. Ther. pmid:19270532
Hara D et al. Persistent BDNF exon I-IX mRNA expression following the withdrawal of neuronal activity in neurons. 2009 Biochem. Biophys. Res. Commun. pmid:19818730
Tan HH and Porter AG p21(WAF1) negatively regulates DNMT1 expression in mammalian cells. 2009 Biochem. Biophys. Res. Commun. pmid:19275888
Li C et al. Induction of myelogenous leukemia cells with histone deacetylase inhibitors through down-regulating the Daxx protein expression. 2009 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:19821084
Gavin DP et al. Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population. 2009 J Psychiatr Res pmid:19187942
Liberatore RA et al. NF-kappaB activity is constitutively elevated in c-Abl null fibroblasts. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19805123
Sasaki K et al. Real-time imaging of histone H4 hyperacetylation in living cells. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19805290
Gibbs A et al. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19805354
Popova EY et al. Chromatin condensation in terminally differentiating mouse erythroblasts does not involve special architectural proteins but depends on histone deacetylation. 2009 Chromosome Res. pmid:19172406
Tsuji Y et al. The developmental potential of mouse somatic cell nuclear-transferred oocytes treated with trichostatin A and 5-aza-2'-deoxycytidine. 2009 Zygote pmid:19175955
Lee JH et al. Notch signal activates hypoxia pathway through HES1-dependent SRC/signal transducers and activators of transcription 3 pathway. 2009 Mol. Cancer Res. pmid:19808903